Linus Olson

Dr. Linus Olson

Karolinska Insitutet
+4
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2009 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
BHBoubou Hallberg
Boubou Hallberg
LOLinus Olson
Linus Olson
MBMarco Bartocci
Marco Bartocci
IEIngela Edqvist
Ingela Edqvist
MBMats Blennow
Mats Blennow

1 April 2015 in Seminars in Fetal and Neonatal Medicine
Verified
Journal Article
Closed access
Paolo MontaldoPaolo Montaldo
Paolo Montaldo
SPShreela S. Pauliah
Shreela S. Pauliah
PLPeter J. Lally
Peter J. Lally
LOLinus Olson
Linus Olson
STSudhin Thayyil
Sudhin Thayyil

7 August 2008 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
JCJakob Carlsson
Jakob Carlsson
HLHugo Lagercrantz
Hugo Lagercrantz
LOLinus Olson
Linus Olson
GPGordana Printz
Gordana Printz
MBMarco Bartocci
Marco Bartocci

5 February 2021 in Acta Paediatrica
Verified
Journal Article
Open access
PDF file
MLMattias Larsson
Mattias Larsson
HNHoa Quynh Nguyen
Hoa Quynh Nguyen
LOLinus Olson
Linus Olson
TTToan Khanh Tran
Toan Khanh Tran
TNTrung Vu Nguyen
Trung Vu Nguyen
CNChuc Thi Kim Nguyen
Chuc Thi Kim Nguyen
Aim: This study assessed the Streptococcus pneumoniae colonisation rate and susceptibility to antibiotics among preschool children in rural Vietnam.Method: Nasopharyngeal samples were collected from 546 preschool children aged 6–59 months living in 460 households in the rural BaVi District of Hanoi and their main caregivers completed questionnaires. The samples were cultured, and the Streptococcus pneumoniae colonisation rate and antibiotic susceptibility were investigated. Resistance data from this 2014 study were compared with studies in 1999 and 2007, to identify 15‐year trends, together with clinical isolates from a national surveillance system of 16 Vietnamese hospital laboratories established in 2013.Results: We found that 221/546 (40%) of the cultures were positive for Streptococcus pneumoniae. The susceptibility rates were trimethoprim‐sulphamethoxazole (5%), erythromycin (8%), ciprofloxacin (12%), benzyl‐penicillin (35%), tetracycline (49%), cefotaxime (55%), moxifloxacin (99%) and vancomycin (99%). All the susceptibility rates were lower in 2014 than 1999 and 2007, except tetracycline. Multi‐drug resistance was 80% in 2014, compared to 60% in 2007 and 31% in 1999. Antibiotics was reported used by 191 (35%) within one month, mainly cephalosporins 86 (45%), amoxycillin/ampicillin 69 (36%) and macrolides 30 (16%).Conclusion: Streptococcus pneumoniae showed remarkable high resistance to commonly used antibiotics, including cephalosporins. Multi‐drug resistance rose from 31% to 80% during the 15‐year study period.

1 January 2021 in Emerging Infectious Diseases
Verified
Journal Article
Closed access
CDCuong Duy
Cuong Duy
VNVuong Minh Nong
Vuong Minh Nong
ANAn Van Ngo
An Van Ngo
TDTra Thu Doan
Tra Thu Doan
TNTuan Quang Nguyen
Tuan Quang Nguyen
MLMattias Larsson
Mattias Larsson
We report on the public health response generated by an outbreak of coronavirus disease (COVID-19) that occurred during March 2020 at Bach Mai Hospital (BMH) in Hanoi, northern Vietnam’s largest hospital complex. On March 18, a total of 3 distinct clusters of COVID-19 cases were identified at BMH. Diagnosis of the initial 3 COVID-19 cases led to contact tracing, symptom screening, and testing of 495 persons and limited quarantine of affected institutes or departments. When 27 staff members in the catering company tested positive for SARS-CoV-2, the entire BMH staff (7,664 persons) was put under quarantine. Contact tracing in the community resulted in an additional 52,239 persons being quarantined. After 3 weeks, the hospital outbreak was contained; no further spread occurred in the hospital. Rapid screening of cases, extensive testing, prompt quarantine, contact tracing, and social distancing contributed to prevent community transmission in Hanoi and northern Vietnam.

16 October 2019 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
BBBjörn Berglund
Björn Berglund
NHNgoc Thi Bich Hoang
Ngoc Thi Bich Hoang
MTMaria Tärnberg
Maria Tärnberg
NLNgai Kien Le
Ngai Kien Le
MNMaud Nilsson
Maud Nilsson
HHHåkan Hanberger
Håkan Hanberger
Background: Carbapenem-resistant Klebsiella pneumoniae are becoming increasingly common in hospital settings worldwide and are a source of increased morbidity, mortality and health care costs. The global epidemiology of carbapenem-resistant K. pneumoniae is characterized by different strains distributed geographically, with the strain ST258 being predominant in Europe and USA, and ST11 being most common in East Asia. ST15 is a less frequently occurring strain but has nevertheless been reported worldwide as a source of hospital outbreaks of carbapenem-resistant K. pneumoniae. Methods: In this study, whole-genome sequencing and antimicrobial susceptibility testing was used to characterize 57 clinical isolates of carbapenem-resistant K. pneumoniae belonging to a strain of ST15, which were collected at a Vietnamese pediatric hospital from February throughout September 2015. Results: Aside from the carbapenem resistance gene blaKPC-2, which was carried by all isolates, prevalence of resistance genes to other antibiotics including aminoglycosides, macrolides, quinolones, fosfomycin and trimethoprim, was also high. All isolates were multidrug-resistant. Susceptibility was highest to ceftazidime/avibactam (96%), gentamicin (91%) and tigecycline (82%). Notably, the colistin resistance rate was very high (42%). Single-nucleotide polymorphism analysis indicated that most isolates belonged to a single clone. Conclusions: The diverse variety of antibiotic resistance genes and the high antibiotic resistance rates to last-resort antibiotics such as carbapenems and colistin, is indicative of a highly adaptable strain. This emphasizes the importance of implementation of infection controls measures, continued monitoring of antibiotic resistance and prudent use of antibiotics to prevent further selection of resistant strains and the emergence of pan-resistant clones.